These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

333 related articles for article (PubMed ID: 23383076)

  • 21. Sodium bicarbonate for the prevention of contrast-induced nephropathy: a meta-analysis of 17 randomized trials.
    Kanbay M; Covic A; Coca SG; Turgut F; Akcay A; Parikh CR
    Int Urol Nephrol; 2009; 41(3):617-27. PubMed ID: 19396567
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of combination therapy of high-dose oral N-acetylcysteine and intravenous sodium bicarbonate hydration with individual therapies in the reduction of Contrast-induced Nephropathy during Cardiac Catheterisation and Percutaneous Coronary Intervention (CONTRAST): A multi-centre, randomised, controlled trial.
    Chong E; Poh KK; Lu Q; Zhang JJ; Tan N; Hou XM; Ong HY; Azan A; Chen SL; Chen JY; Ali RM; Fang WY; Lau TW; Tan HC
    Int J Cardiol; 2015 Dec; 201():237-42. PubMed ID: 26301645
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of intravenous hydration on risk of contrast induced nephropathy and in-hospital mortality in STEMI patients undergoing primary percutaneous coronary intervention: a systematic review and meta-analysis of randomized controlled trials.
    Liu Y; Hong D; Wang AY; Guo R; Smyth B; Liu J; Sun G; Chen S; Tan N; Jardine M; Brieger D; Shaman A; Islam S; Chen J; Gallagher M
    BMC Cardiovasc Disord; 2019 Apr; 19(1):87. PubMed ID: 30961544
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A meta-analysis of N-acetylcysteine in contrast-induced nephrotoxicity: unsupervised clustering to resolve heterogeneity.
    Gonzales DA; Norsworthy KJ; Kern SJ; Banks S; Sieving PC; Star RA; Natanson C; Danner RL
    BMC Med; 2007 Nov; 5():32. PubMed ID: 18001477
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Efficacy of short-term high-dose statin in preventing contrast-induced nephropathy: a meta-analysis of seven randomized controlled trials.
    Li Y; Liu Y; Fu L; Mei C; Dai B
    PLoS One; 2012; 7(4):e34450. PubMed ID: 22511942
    [TBL] [Abstract][Full Text] [Related]  

  • 26. N-acetylcysteine for the prevention of radiocontrast induced nephropathy: a meta-analysis of prospective controlled trials.
    Kshirsagar AV; Poole C; Mottl A; Shoham D; Franceschini N; Tudor G; Agrawal M; Denu-Ciocca C; Magnus Ohman E; Finn WF
    J Am Soc Nephrol; 2004 Mar; 15(3):761-9. PubMed ID: 14978179
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Trimetazidine Decreases Risk of Contrast-Induced Nephropathy in Patients With Chronic Kidney Disease: A Meta-Analysis of Randomized Controlled Trials.
    Nadkarni GN; Konstantinidis I; Patel A; Yacoub R; Kumbala D; Patel RA; Annapureddy N; Pakanati KC; Simoes PK; Javed F; Benjo AM
    J Cardiovasc Pharmacol Ther; 2015 Nov; 20(6):539-46. PubMed ID: 25715308
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Intravenous N-acetylcysteine plus high-dose hydration versus high-dose hydration and standard hydration for the prevention of contrast-induced nephropathy: CASIS--a multicenter prospective controlled trial.
    Koc F; Ozdemir K; Kaya MG; Dogdu O; Vatankulu MA; Ayhan S; Erkorkmaz U; Sonmez O; Aygul MU; Kalay N; Kayrak M; Karabag T; Alihanoglu Y; Gunebakmaz O
    Int J Cardiol; 2012 Mar; 155(3):418-23. PubMed ID: 21106264
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Is treatment with N-acetylcysteine to prevent contrast-induced nephropathy when using bicarbonate hydration out of date?
    Heng AE; Cellarier E; Aublet-Cuvelier B; Decalf V; Motreff P; Marcaggi X; Deteix P; Souweine B
    Clin Nephrol; 2008 Dec; 70(6):475-84. PubMed ID: 19049703
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effectiveness of Prevention Strategies for Contrast-Induced Nephropathy: A Systematic Review and Meta-analysis.
    Subramaniam RM; Suarez-Cuervo C; Wilson RF; Turban S; Zhang A; Sherrod C; Aboagye J; Eng J; Choi MJ; Hutfless S; Bass EB
    Ann Intern Med; 2016 Mar; 164(6):406-16. PubMed ID: 26830221
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The role of N-acetylcysteine in preventing radiographic contrast-induced nephropathy.
    Guru V; Fremes SE
    Clin Nephrol; 2004 Aug; 62(2):77-83. PubMed ID: 15356963
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prevention of acute renal failure post-contrast imaging in cardiology: a randomized study.
    Alessandri N; Lanzi L; Garante CM; Tersigni F; Sergiacomi R; Petrassi M; Di Matteo A; Tufano F
    Eur Rev Med Pharmacol Sci; 2013 Feb; 17 Suppl 1():13-21. PubMed ID: 23436661
    [TBL] [Abstract][Full Text] [Related]  

  • 33. N-acetylcysteine for the prevention of contrast-induced nephropathy. A systematic review and meta-analysis.
    Liu R; Nair D; Ix J; Moore DH; Bent S
    J Gen Intern Med; 2005 Feb; 20(2):193-200. PubMed ID: 15836554
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Acetylcysteine for prevention of contrast-induced nephropathy after intravascular angiography: a systematic review and meta-analysis.
    Bagshaw SM; Ghali WA
    BMC Med; 2004 Oct; 2():38. PubMed ID: 15500690
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Acetylcysteine for prevention of contrast nephropathy: meta-analysis.
    Birck R; Krzossok S; Markowetz F; Schnülle P; van der Woude FJ; Braun C
    Lancet; 2003 Aug; 362(9384):598-603. PubMed ID: 12944058
    [TBL] [Abstract][Full Text] [Related]  

  • 36. N-acetylcysteine does not prevent contrast-induced nephropathy after cardiac catheterization in patients with diabetes mellitus and chronic kidney disease: a randomized clinical trial.
    Amini M; Salarifar M; Amirbaigloo A; Masoudkabir F; Esfahani F
    Trials; 2009 Jun; 10():45. PubMed ID: 19563648
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The role of N--acetylcysteine in the prevention of contrast-induced nephropathy in patients undergoing peripheral angiography: a structured review and meta-analysis.
    O'Sullivan S; Healy DA; Moloney MC; Grace PA; Walsh SR
    Angiology; 2013 Nov; 64(8):576-82. PubMed ID: 23188834
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Acetylcysteine in the prevention of contrast-induced nephropathy after coronary angiography.
    Oldemeyer JB; Biddle WP; Wurdeman RL; Mooss AN; Cichowski E; Hilleman DE
    Am Heart J; 2003 Dec; 146(6):E23. PubMed ID: 14661012
    [TBL] [Abstract][Full Text] [Related]  

  • 39. N-acetylcysteine for the prevention of contrast-induced nephropathy in the emergency department.
    Hsu TF; Huang MK; Yu SH; Yen DH; Kao WF; Chen YC; Huang MS
    Intern Med; 2012; 51(19):2709-14. PubMed ID: 23037460
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Preventive effect of N-acetylcysteine on contrast-induced nephropathy following coronary angiography and angioplasty.
    Kamiyama N; Ogawa R; Hamada H; Ohno T; Asano R; Umemura J; Yoshida H
    Yakugaku Zasshi; 2008 Sep; 128(9):1333-9. PubMed ID: 18758148
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.